A novel autoantibody against fibronectin leucine-rich transmembrane protein 2 expressed on the endothelial cell surface identified by retroviral vector system in systemic lupus erythematosus

Arthritis Research and Therapy

Volumn 14, Issue 4, 2012, Pages

  Shirai, Tsuyoshi ^a   Fujii, Hiroshi ^a   Ono, Masao ^a   Nakamura, Kyohei ^a   Watanabe, Ryu ^a   Tajima, Yumi ^a   Takasawa, Naruhiko ^a   Ishii, Tomonori ^a   Harigae, Hideo ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; ENDOTHELIAL CELL ANTIBODY; FIBRONECTIN LEUCINE RICH TRANSMEMBRANE PROTEIN 2; IMMUNOGLOBULIN G; MEMBRANE PROTEIN; RETROVIRUS VECTOR; UNCLASSIFIED DRUG; AUTOANTIBODY; FLRT2 PROTEIN, HUMAN;

ANIMAL CELL; ANTIBODY BLOOD LEVEL; ARTICLE; CELL SURFACE; COMPLEMENT DEPENDENT CYTOTOXICITY; CONTROLLED STUDY; DNA LIBRARY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOGLOBULIN BLOOD LEVEL; MYELOMA CELL; NONHUMAN; PROTEIN EXPRESSION; RAT; RETROVIRUS; SYSTEMIC LUPUS ERYTHEMATOSUS; UMBILICAL VEIN ENDOTHELIAL CELL; ADOLESCENT; ADULT; AGED; ANIMAL; BIOSYNTHESIS; BLOOD; CELL MEMBRANE; DIAGNOSTIC USE; FEMALE; GENE EXPRESSION REGULATION; GENE VECTOR; GENETICS; HEK293 CELL LINE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; METABOLISM; MIDDLE AGED; RETROVIRIDAE; VASCULAR ENDOTHELIUM; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANIMALS; AUTOANTIBODIES; CELL MEMBRANE; ENDOTHELIUM, VASCULAR; FEMALE; GENE EXPRESSION REGULATION; GENETIC VECTORS; HEK293 CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MEMBRANE PROTEINS; MIDDLE AGED; RATS; RETROVIRIDAE; YOUNG ADULT;

EID: 84863090672     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3897     Document Type: Article

References (50)

1. Lindqvist KJ, Osterland CK. Human antibodies to vascular endothelium. Clin Exp Immunol 1971, 96:753-760.
2. Guilpain P, Mouthon L. Antiendothelial cells autoantibodies in vasculitis-associated systemic diseases. Clin Rev Allergy Immunol 2008, 35:59-65. 10.1007/s12016-007-8069-3, 18228162.
3. D'Cruz DP, Houssiau FA, Ramirez G, Baguley E, McCutcheon J, Vianna J, Haga HJ, Swana GT, Khamashta MA, Taylor JC, Davies DR, Hughes GR. Antibodies to endothelial cells in systemic lupus erythematosus: a potential marker for nephritis and vasculitis. Clin Exp Immunol 1991, 85:254-261. 1535753, 1864005.
4. Renaudineau Y, Dugué C, Dueymes M, Youinou P. Antiendothelial cell antibodies in systemic lupus erythematosus. Autoimmun Rev 2002, 1:365-372. 10.1016/S1568-9972(02)00063-0, 12848993.
5. Soltesz P, Bereczki D, Szodoray P, Magyar MT, Der H, Csipo I, Hajas A, Paragh G, Szegedi G, Bodolay E. Endothelial cell markers reflecting endothelial cell dysfunction in patients with mixed connective tissue disease. Arthritis Res Ther 2010, 12:R78. 10.1186/ar2999, 2911856, 20459625.
6. Mihai C, Tervaert JW. Anti-endothelial cell antibodies in systemic sclerosis. Ann Rheum Dis 2010, 69:319-324. 10.1136/ard.2008.102400, 20107031.
7. Chauhan SK, Tripathy NK, Nityanand S. Antigenic targets and pathogenicity of anti-aortic endothelial cell antibodies in Takayasu arteritis. Arthritis Rheum 2006, 54:2326-2333. 10.1002/art.21921, 16802373.
8. Del Papa N, Guidali L, Sironi M, Shoenfeld Y, Mantovani A, Tincani A, Balestrieri G, Radice A, Sinico RA, Meroni PL. Anti-endothelial cell IgG antibodies from patients with Wegener's granulomatosis bind to human endothelial cells in vitro and induce adhesion molecule expression and cytokine secretion. Arthritis Rheum 1996, 39:758-766. 10.1002/art.1780390507, 8639172.
9. Ahmed SS, Tan FK, Arnett FC, Jin L, Geng YJ. Induction of apoptosis and fibrillin 1 expression in human dermal endothelial cells by scleroderma sera containing anti-endothelial cell antibodies. Arthritis Rheum 2006, 54:2250-2262. 10.1002/art.21952, 16802364.
10. Hahn BH. Targeted therapies in systemic lupus erythematosus: successes, failures and future. Ann Rheum Dis 2011, 70(Suppl 1):i64-i66. 10.1136/ard.2010.142208, 21339222.
11. Bloom O, Cheng KF, He M, Papatheodorou A, Volpe BT, Diamond B, Al-Abed Y. Generation of a unique small molecule peptidomimetic that neutralizes lupus autoantibody activity. Proc Natl Acad Sci USA 2011, 108:10255-10259. 10.1073/pnas.1103555108, 3121823, 21646518.
12. Youinou P. New target antigens for anti-endothelial cell antibodies. Immunobiology 2005, 210:789-797. 10.1016/j.imbio.2005.10.011, 16325499.
13. Naparstek Y, Plotz PH. The role of autoantibodies in autoimmune disease. Annu Rev Immunol 1993, 11:79-104. 10.1146/annurev.iy.11.040193.000455, 8476578.
14. Racanelli V, Prete M, Musaraj G, Dammacco F, Perosa F. Autoantibodies to intracellular antigens: generation and pathogenetic role. Autoimmun Rev 2011, 10:503-508. 10.1016/j.autrev.2011.03.001, 21397735.
15. Praprotnik S, Blank M, Meroni PL, Rozman B, Eldor A, Shoenfeld Y. Classification of anti-endothelial cell antibodies into antibodies against microvascular and macrovascular endothelial cells: the pathogenic and diagnostic implications. Arthritis Rheum 2001, 44:1484-1494. 10.1002/1529-0131(200107)44:7<1484::AID-ART269>3.0.CO;2-Q, 11465698.
16. Karasawa R, Kurokawa MS, Yudoh K, Masuko K, Ozaki S, Kato T. Peroxiredoxin 2 is a novel autoantigen for anti-endothelial cell antibodies in systemic vasculitis. Clin Exp Immunol 2010, 161:459-470. 10.1111/j.1365-2249.2010.04218.x, 2962963, 20646000.
17. Dieudé M, Senécal JL, Raymond Y. Induction of endothelial cell apoptosis by heat-shock protein 60-reactive antibodies from anti-endothelial cell autoantibody-positive systemic lupus erythematosus patients. Arthritis Rheum 2004, 50:3221-3231. 10.1002/art.20564, 15476243.
18. Kitamura T, Koshino Y, Shibata F, Oki T, Nakajima H, Nosaka T, Kumagai H. Retrovirus-mediated gene transfer and expression cloning: powerful tools in functional genomics. Exp Hematol 2003, 31:1007-1014.
19. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982, 25:1271-1277. 10.1002/art.1780251101, 7138600.
20. Alarcón-Segovia D, Cardiel MH. Comparison between three diagnostic criteria for mixed connective tissue disease: study of 593 patients. J Rheumatol 1989, 16:328-334.
21. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002, 61:554-558. 10.1136/ard.61.6.554, 1754137, 12006334.
22. Bohan A, Peter JB. Polymyositis and dermatomyositis (parts 1 and 2). N Engl J Med 1975, 292:344-347. 403-407, 10.1056/NEJM197502132920706, 1090839.
23. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980, 23:581-590. 10.1002/art.1780230510, 7378088, Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.
24. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, Combe B, Costenbader KH, Dougados M, Emery P, Ferraccioli G, Hazes JM, Hobbs K, Huizinga TW, Kavanaugh A, Kay J, Kvien TK, Laing T, Mease P, Ménard HA, Moreland LW, Naden RL, Pincus T, Smolen JS, Stanislawska-Biernat E, Symmons D, Tak PP, Upchurch KS, Vencovský J, Wolfe F, Hawker G. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010, 62:2569-2581. 10.1002/art.27584, 20872595.
25. Miyakis S, Lockshin MD, Atsumi T, Branch DC, Brey RL, Cervera R, Derksen RH, De Groot PG, Koike T, Meroni PL, Reber G, Shoenfeld Y, Tincani A, Vlachoyiannopoulos PG, Krilis SA. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006, 4:295-306. 10.1111/j.1538-7836.2006.01753.x, 16420554.
26. Lightfoot RW, Michel BA, Bloch DA, Hunder GG, Zvaifler NJ, McShane DJ, Arend WP, Calabrese LH, Leavitt RY, Lie JT, Masi AT, Mills JA, Stevens MB, Wallace SL. The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum 1990, 33:1088-1093.
27. Masi AT, Hunder GG, Lie JT, Michel BA, Bloch DA, Arend WP, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY, Lightfoot RW, McShane DJ, Mills JA, Stevens MB, Wallace SL, Zvaifler NJ. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 1990, 33:1094-1100.
28. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, Hagen EC, Hoffman GS, Hunder GG, Kallenberg CG, McCluskey RT, Sinico RA, Rees AJ, Van Es LA, Waldherr R, Wiik A. Nomenclature of systemic vasculitides: proposal of an international consensus conference. Arthritis Rheum 1994, 37:187-192. 10.1002/art.1780370206, 8129773.
29. Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP, Calabrese LH, Fries JF, Lie JT, Lightfoot RE, Masi AT, McShane DJ, Mills JA, Stevens MB, Wallace SL, Zvaifler NJ. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990, 33:1101-1107.
30. Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY, Lie JT, Lightfoot RW, Masi AT, McShane DJ, Mills JA, Wallace SL, Zvaifler NJ. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990, 33:1122-1128.
31. Arend WP, Michel BA, Bloch DA, Hunder GG, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY, Lie JT, Lightfoot RW, Masi AT, McShane DJ, Mills JA, Stevens MB, Wallace SL, Zvaifler NJ. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum 1990, 33:1129-1134.
32. Tunç R, Uluhan A, Melikoǧlu M, Ozyazgan Y, Ozdoǧan H, Yazici H. A reassessment of the International Study Group criteria for the diagnosis (classification) of Behçet's syndrome. Clin Exp Rheumatol 2001, 19(Suppl):45-47.
33. Bordron A, Révélen R, D'Arbonneau F, Dueymes M, Renaudineau Y, Jamin C, Youinou P. Functional heterogeneity of anti-endothelial cell antibodies. Clin Exp Immunol 2001, 124:492-501. 10.1046/j.1365-2249.2001.01528.x, 1906088, 11472414.
34. Morita S, Kojima T, Kitamura T. Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther 2000, 7:1063-1066. 10.1038/sj.gt.3301206, 10871756.
35. Tripathy NK, Upadhyaya S, Sinha N, Nityanand S. Complement and cell mediated cytotoxicity by antiendothelial cell antibodies in Takayasu's arteritis. J Rheumatol 2001, 28:805-808.
36. Idusogie EE, Presta LG, Gazzano-Santoro H, Totpal K, Wong PY, Ultsch M, Meng YG, Mulkerrin MG. Mapping of the C1q binding site on rituxan, a chimeric antibody with a human IgG1 Fc. J Immunol 2000, 164:4178-4184.
37. Yamane-Ohnuki N, Kinoshita S, Inoue-Urakubo M, Kusunoki M, Iida S, Nakano R, Wakitani M, Niwa R, Sakurada M, Uchida K, Shitara K, Satoh M. Establishment of FUT8 knockout Chinese hamster ovary cells: an ideal host cell line for producing completely defucosylated antibodies with enhanced antibody-dependent cellular cytotoxicity. Biotechnol Bioeng 2004, 87:614-622. 10.1002/bit.20151, 15352059.
38. Lacy SE, Bönnemann CG, Buzney EA, Kunkel LM. Identification of FLRT1, FLRT2, and FLRT3: a novel family of transmembrane leucine-rich repeat proteins. Genomics 1999, 62:417-426. 10.1006/geno.1999.6033, 10644439.
39. Suzuki J, Umeda M, Sims PJ, Nagata S. Calcium-dependent phospholipid scrambling by TMEM16F. Nature 2010, 468:834-838. 10.1038/nature09583, 21107324.
40. Alard JE, Dueymes M, Youinou P, Jamin C. Modulation of endothelial cell damages by anti-Hsp60 autoantibodies in systemic autoimmune diseases. Autoimmun Rev 2007, 6:438-443. 10.1016/j.autrev.2007.01.012, 17643930.
41. Jamin C, Dugué C, Alard JE, Jousse S, Saraux A, Guillevin L, Piette JC, Youinou P. Induction of endothelial cell apoptosis by the binding of anti-endothelial cell antibodies to Hsp60 in vasculitis-associated systemic autoimmune diseases. Arthritis Rheum 2005, 52:4028-4038. 10.1002/art.21401, 16320351.
42. Yamagishi S, Hampel F, Hata K, Del Toro D, Schwark M, Kvachnina E, Bastmeyer M, Yamashita T, Tarabykin V, Klein R, Egea J. FLRT2 and FLRT3 act as repulsive guidance cues for Unc5-positive neurons. EMBO J 2011, 30:2920-2933. 10.1038/emboj.2011.189, 21673655.
43. Wei K, Xu Y, Tse H, Manolson MF, Gong SG. Mouse FLRT 2 interacts with the extracellular and intracellular regions of FGFR2. J Dent Res 2011, 90:1234-1239. 10.1177/0022034511415272, 21765038.
44. Xu Y, Wei K, Kulyk W, Gong SG. FLRT2 promotes cellular proliferation and inhibits cell adhesion during chondrogenesis. J Cell Biochem 2011, 112:3440-3448. 10.1002/jcb.23271, 21769912.
45. Gong SG, Mai S, Chung K, Wei K. Flrt2 and Flrt3 have overlapping and non-overlapping expression during craniofacial development. Gene Expr Patterns 2009, 9:497-502. 10.1016/j.gep.2009.07.009, 19635589.
46. Müller PS, Schulz R, Maretto S, Costello I, Srinivas S, Bikoff E, Robertson E. The fibronectin leucine-rich repeat transmembrane protein Flrt2 is required in the epicardium to promote heart morphogenesis. Development 2011, 138:1297-1308. 10.1242/dev.059386, 3050662, 21350012.
47. Leung DY, Moake JL, Havens PL, Kim M, Pober JS. Lytic anti-endothelial cell antibodies in haemolytic-uraemic syndrome. Lancet 1988, 2:183-186.
48. Fujieda M, Oishi N, Kurashige T. Antibodies to endothelial cells in Kawasaki disease lyse endothelial cells without cytokine pretreatment. Clin Exp Immunol 1997, 107:120-126. 10.1046/j.1365-2249.1997.d01-894.x, 1904559, 9010266.
49. Salmon JE, Roman MJ. Subclinical atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus. Am J Med 2008, 121(Suppl 1):3-8.
50. Roman MJ, Shanker BA, Davis A, Lockshin MD, Sammaritano L, Simantov R, Crow MK, Schwartz JE, Paget SA, Devereux RB, Salmon JE. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003, 349:2399-2406. 10.1056/NEJMoa035471, 14681505.